Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,828

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Venous ThromboembolismCancer
Interventions
DRUG

Rivaroxaban 10 MG

Identical comparator drug

Trial Locations (11)

Unknown

RECRUITING

Nova Scotia Health, Halifax

RECRUITING

Centre Intégré de santé et de services sociaux de Chaudière-Appalaches, Lévis

RECRUITING

McGill University Health Center, Montreal

L6R 3J7

RECRUITING

William Osler Health System, Brampton

L8V 1C3

RECRUITING

HHS - Juravinski Hospital, Hamilton

K1H8L6

RECRUITING

Ottawa Hospital Research Institute- The Ottawa Hospital, Ottawa

750 Great Northern Rd.

RECRUITING

Sault Area Hospital, Sault Ste. Marie

L2S0A9

RECRUITING

Niagara Health, St. Catharines

N8W 1L9

RECRUITING

Windsor Regional Hospital, Windsor

J4V 2H1

RECRUITING

CISSS Montérégie-Centre HOPITAL CHARLES LEMOYNE, Greenfield Park

H3T 1E2

RECRUITING

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER